PON1 and diabetes mellitus: Among these, metabolic diseases such as diabetes mellitus, cardiovascular diseases, and inflammation are the most studied, since they are all characterized by the release of oxidative compounds of different origin [30,31] that may lead to the consumption of antioxidant molecules such as PON-1.